SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Trevena Says FDA Considers New Drug Application Resubmission A Complete Class 2 Response

Benzinga · 03/05/2020 12:33